Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | glutaminase DH11.1 | 0.033 | 0.2054 | 0.4224 |
Echinococcus granulosus | jun protein | 0.0638 | 0.4861 | 0.4861 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.1202 | 1 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.1336 | 0.2747 |
Schistosoma mansoni | jun-related protein | 0.0519 | 0.3772 | 1 |
Echinococcus multilocularis | Ankyrin | 0.0105 | 0.0005 | 0.0005 |
Loa Loa (eye worm) | glutaminase 2 | 0.033 | 0.2054 | 0.4362 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0105 | 0.0005 | 0.0013 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0638 | 0.4861 | 0.4861 |
Schistosoma mansoni | glutaminase | 0.033 | 0.2054 | 0.5445 |
Brugia malayi | bZIP transcription factor family protein | 0.0638 | 0.4861 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0519 | 0.3772 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.1336 | 0.2833 |
Onchocerca volvulus | 0.0501 | 0.3612 | 1 | |
Mycobacterium ulcerans | glutaminase | 0.033 | 0.2054 | 0.5 |
Echinococcus multilocularis | jun protein | 0.0638 | 0.4861 | 0.4861 |
Trichomonas vaginalis | glutaminase, putative | 0.033 | 0.2054 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0638 | 0.4861 | 0.4861 |
Brugia malayi | hypothetical protein | 0.0501 | 0.3612 | 0.7431 |
Echinococcus granulosus | Ankyrin | 0.0105 | 0.0005 | 0.0005 |
Loa Loa (eye worm) | hypothetical protein | 0.0621 | 0.4702 | 1 |
Loa Loa (eye worm) | glutaminase | 0.033 | 0.2054 | 0.4362 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.